from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3274c/fadE25

LFCtreatmentdescriptionclass of inhibitor

0.533

Amikacinug/mL Amikacintranslation

0.637

Cap5-10ug/mL Capreomycintranslation

0.304

Rox10-50 ug/mL Roxithromycintranslation

0.761

SM2-5 ug/mL Streptomycintranslation

-0.070

Tet5-10 ug/mL Tetracyclinetranslation

0.869

Rif0.2-5ug/mL Rifampicintranscription

-0.119

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.248

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.176

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.216

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.635

Clofazimine10-13 ug/mL Clofaziminerespiration

0.107

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.077

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.094

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.380

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.068

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.312

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.084

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.671

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.598

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.708

KCN5-20 ug/mL Potassium cyaniderespiration

0.045

NaN30.2-2 mM Sodium aziderespiration

0.538

Nigericin50 uM Nigericinrespiration

-0.655

TRC10-150 ug/mL Triclosanrespiration

-1.529

TRZ10-25 ug/mL Thioridazinerespiration

-0.656

Valinomycin0.5-10 uM Valinomycinrespiration

0.620

ZnSO42 mM ZnSO4respiration

0.827

menadione6-10 ug/mL Menadionerespiration

-0.730

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.371

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.107

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.922

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.145

NRP_1Non-replicating persistence stage 1dosRassociated

0.538

Amp0.2mg/mL AmpicillincellWall

0.518

Cephalexin20-100 ug/mL CephalexincellWall

0.603

Cerulenin0.32-5 ug/mL CerulenincellWall

0.460

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.300

EMB10-20 ug/mL EthambutolcellWall

0.885

Eta12-40 ug/mL EthionamidecellWall

0.852

INH0.2-0.4 ug/mL IsoniazidcellWall

0.776

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.190

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.559

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.487

BZA0.12 mg/mL BenzamidearomaticAmides

0.019

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.247

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.382

H2O24 mM hydrogen peroxideDNAdamaging

0.549

Levo10 ug/mL LevofloxacinDNAdamaging

0.668

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.346

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.866

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.658

UVUV-irradiationDNAdamaging

-0.862

ARP41-4 ug/mL Antitubercular compound ARP4?

0.422

Antimycin12.5-50 ug/mL Antimycin A?

0.763

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.432

PA_110-50 ug/mL Antitubercular compound PA-1?

0.394

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.754

PA8240.2-2 ug/mL PA-824?

-0.907

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.194

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.173

Verapamil50 uM Verapamil?

0.538

mercaptoethanol2 mM 2-Mercaptoethanol?

0.302

methoxatin10-20 ug/mL Methoxatin?